TY - JOUR
T1 - Molecular role(s) for integrins in human melanoma invasion
AU - Seftor, Richard E.B.
AU - Seftor, Elisabeth A.
AU - Hendrix, Mary J.C.
N1 - Funding Information:
The authors acknowledge the contribution of uveal melanoma cell lines from Drs. Karla Daniels and Robert Folberg from the University of Iowa, Dr. Jun Kan-Mitchell from The University of California, and Dr. Jacob Pe’er from the Hadassah University Hospital, Jerusalem, Israel. This research was supported by NIH/NCI grants RO1CA59702, R21CA83137 and RO1CA80318.
PY - 1999
Y1 - 1999
N2 - There are fundamental issues regarding the role of integrins in human disease which remain to be elucidated. Human cutaneous melanoma is an attractive model for studying integrin involvement in tumor progression because it generally follows a sequential series of definable stages. Furthermore, the most specific marker for the transition of cells from the more benign, non-metastatic radial growth phase stage to the more malignant, metastatically competent vertical growth phase stage is associated with the onset of α(v)β3 integrin expression and function. This same pattern, however, does not hold true for human ocular/uveal melanomas which do not progress through these stages, but preferentially metastasize to the liver by dissemination of the cells via a direct hematogenous pathway. It is also unclear whether the α(v)β3 integrin is functionally involved in uveal melanoma metastasis or not. Our results show that perturbation of the α(v)β3 integrin on moderately invasive A375M human cutaneous melanoma cells with either specific antibodies or ligands results in an increase in the cells' ability to invade in vitro coincident with an increase in the cells' expression and extracellular levels of matrix metalloproteinase-2 (MMP-2, gelatinase A). The highly invasive C8161 human cutaneous melanoma cells express little-to-no α(v)β3 integrin, but are more invasive and express higher levels of MMPs after perturbation of their α5β1 integrin. This augmented invasiveness could subsequently be abrogated with a function- blocking anti-MMP-2 antibody. Primary uveal melanoma cells and cells derived from uveal metastases appear to grow in either a spindle or epithelioid morphology. The less invasive uveal melanoma cells are spindle shaped and express higher levels of the α(v)β3 integrin, while the more invasive cell lines are epithelioid shaped and express reduced levels of the α(v)β3 integrin. The apparent conflict between these results and the current model for cutaneous melanoma progression may be addressed as follows: The expression and function of the α(v)β3 integrin plays an important role(s) during the transition of cells from the radial growth phase stage to the vertical growth phase stage. However, further progression leading to metastases may require changes in the cells' integrins that would facilitate their ability to leave the primary tumor, and aid in their ability to invade and ultimately form metastases. It is also conceivable that the α(v)β3 integrin is reexpressed during various stages of metastatic dissemination, and, in particular, during tumor reestablishment.
AB - There are fundamental issues regarding the role of integrins in human disease which remain to be elucidated. Human cutaneous melanoma is an attractive model for studying integrin involvement in tumor progression because it generally follows a sequential series of definable stages. Furthermore, the most specific marker for the transition of cells from the more benign, non-metastatic radial growth phase stage to the more malignant, metastatically competent vertical growth phase stage is associated with the onset of α(v)β3 integrin expression and function. This same pattern, however, does not hold true for human ocular/uveal melanomas which do not progress through these stages, but preferentially metastasize to the liver by dissemination of the cells via a direct hematogenous pathway. It is also unclear whether the α(v)β3 integrin is functionally involved in uveal melanoma metastasis or not. Our results show that perturbation of the α(v)β3 integrin on moderately invasive A375M human cutaneous melanoma cells with either specific antibodies or ligands results in an increase in the cells' ability to invade in vitro coincident with an increase in the cells' expression and extracellular levels of matrix metalloproteinase-2 (MMP-2, gelatinase A). The highly invasive C8161 human cutaneous melanoma cells express little-to-no α(v)β3 integrin, but are more invasive and express higher levels of MMPs after perturbation of their α5β1 integrin. This augmented invasiveness could subsequently be abrogated with a function- blocking anti-MMP-2 antibody. Primary uveal melanoma cells and cells derived from uveal metastases appear to grow in either a spindle or epithelioid morphology. The less invasive uveal melanoma cells are spindle shaped and express higher levels of the α(v)β3 integrin, while the more invasive cell lines are epithelioid shaped and express reduced levels of the α(v)β3 integrin. The apparent conflict between these results and the current model for cutaneous melanoma progression may be addressed as follows: The expression and function of the α(v)β3 integrin plays an important role(s) during the transition of cells from the radial growth phase stage to the vertical growth phase stage. However, further progression leading to metastases may require changes in the cells' integrins that would facilitate their ability to leave the primary tumor, and aid in their ability to invade and ultimately form metastases. It is also conceivable that the α(v)β3 integrin is reexpressed during various stages of metastatic dissemination, and, in particular, during tumor reestablishment.
KW - Cutaneous melanoma
KW - Integrins
KW - Invasion
KW - Uveal melanoma
UR - http://www.scopus.com/inward/record.url?scp=0033389362&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033389362&partnerID=8YFLogxK
U2 - 10.1023/A:1006317125454
DO - 10.1023/A:1006317125454
M3 - Review article
C2 - 10721490
AN - SCOPUS:0033389362
SN - 0167-7659
VL - 18
SP - 359
EP - 375
JO - Cancer and Metastasis Reviews
JF - Cancer and Metastasis Reviews
IS - 3
ER -